[HTML][HTML] Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: Preclinical and clinical development
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - ncbi.nlm.nih.gov
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
[HTML][HTML] Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - oncotarget.com
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - europepmc.org
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - pubmed.ncbi.nlm.nih.gov
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - iro.uiowa.edu
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
[PDF][PDF] Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
Y Zakharia, A Bhattacharya, YM Rustum - pdfs.semanticscholar.org
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - europepmc.org
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
Y Zakharia, A Bhattacharya, YM Rustum - Oncotarget, 2018 - oncotarget.com
Selenium (Se)-containing molecules exert antioxidant properties and modulate targets
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …
associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention …